Need to Know

Following a recent series on ClinicalTrials.gov “FAQ” sections, the CTSI is exploring quality control and posting procedures.

Part two in a series of articles highlighting frequently asked questions to comply with results reporting for ClinicalTrials.gov includes guidance on the Quality Control review process, protocol and statistical analysis plans, and appendices. (See part one here.)

In the first part of a two-part series, “Research Roundtable” highlights elements of the “Results Reporting” FAQ section from ClinicalTrials.gov.

In the second part of a two-part series, “Research Roundtable” highlights additional elements of the “Study Registration” FAQ section from ClinicalTrials.gov.

ClinicalTrials.gov has an extensive FAQ section ranging from general to investigation-specific. This edition of “Research Roundtable” highlights a selected FAQ, “Study Registration.”

In order to address the specific details and regulatory requirements present in a retrospective medical chart review, the UB IRB recently created a new Protocol template: the HRP-503R.